Get Involved
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
Study Purpose
This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called cemiplimab (each individually called a "study drug" or called "study drugs" when combined) compared with an approved medication called pembrolizumab. The objective of this study is to see if the combination of fianlimab and cemiplimab is an effective treatment compared to pembrolizumab in patients that have had melanoma removal surgery but are still at high risk for the recurrence of the disease. Pembrolizumab is an approved treatment in some countries in this clinical setting. The study is looking at several other research questions, including:
- - What side effects may happen from receiving the study drugs.
- - How much study drug is in the blood at different times.
- - Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects).
- - How administering the study drugs might improve quality of life.
Recruitment Criteria
|
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
|
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
| Eligible Ages | 12 Years and Over |
| Gender | All |
Key
Inclusion Criteria:
1. All patients must be either stage IIB, IIC, III, or stage IV per American Joint Committee on Cancer (AJCC) 8th edition and have histologically confirmed melanoma that is completely surgically resected in order to be eligible as defined by the protocol. 2. Complete surgical resection must be performed within 12 weeks prior to randomization, and enrollment may occur only after satisfactory wound healing from the surgery. 3. All patients must have disease-free status documented by a complete physical examination and imaging studies within 4 weeks prior to randomization, as described in the protocol.KeyExclusion Criteria:
1. Uveal melanoma. 2. Any evidence of residual disease after surgery by imaging, pathology, or cytology. 3. Ongoing or recent (within 2 years) evidence of clinically significant autoimmune disease that required treatment. 4. Uncontrolled infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C (HCV) infection; or diagnosis of immunodeficiency that is related to, or results in chronic infection, as described in the protocol. 5. Another malignancy that is currently progressing or that required active treatment in the past 5 years, as described in the protocol. 6. Participants with a history of myocarditis. 7. Adolescent patients (≥12 to <18 years old) with body weight <40 kg.Note: Other Protocol Defined Inclusion/ Exclusion Criteria ApplyTrial Details
|
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT05608291 |
|
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 3 |
|
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
Regeneron Pharmaceuticals |
|
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Clinical Trial Management |
| Principal Investigator Affiliation | Regeneron Pharmaceuticals |
|
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
Industry |
| Overall Status | Active, not recruiting |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Ireland, Israel, Italy, Mexico, Poland, Romania, South Africa, Spain, Turkey (Türkiye), United Kingdom, United States |
|
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Melanoma |
| Study Website: | View Trial Website |
Arms
Experimental: Fianlimab HD + Cemiplimab
Patients will be administered one combination dose of fianlimab high dose (HD) and cemiplimab
Experimental: Fianlimab LD + Cemiplimab
Patients will be administered one combination dose of fianlimab low dose (LD) and cemiplimab
Active Comparator: Pembrolizumab
Patients will be administered one dose of pembrolizumab co-infused with saline/dextrose placebo
Interventions
Drug: - Fianlimab
Fianlimab will be administered by intravenous (IV) infusion every (Q) 3 weeks
Drug: - Cemiplimab
Cemiplimab will be administered by IV infusion Q 3 weeks
Drug: - Pembrolizumab
Pembrolizumab will be administered by IV infusion Q 3 weeks
Drug: - Placebo
Matching placebo co-infused with pembrolizumab IV, will be administered by IV infusion Q 3 weeks
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Address
UC San Diego
La Jolla 5363943, California 5332921, 92093
Status
Address
UCSF Medical Center at Mission Bay
San Francisco 5391959, California 5332921, 94158
Status
Address
John Wayne Cancer Institute (JWCI)
Santa Monica 5393212, California 5332921, 90404
Status
Address
The Melanoma And Skin Cancer Institute
Englewood 5421250, Colorado 5417618, 80113
Status
Address
Miami Cancer Institute at Baptist Health, Inc.
Miami 4164138, Florida 4155751, 33176
Status
Address
Orlando Health
Orlando 4167147, Florida 4155751, 32806
Status
Address
Moffitt Cancer Center
Tampa 4174757, Florida 4155751, 33612
Status
Address
Northwestern University
Chicago 4887398, Illinois 4896861, 60611
Status
Address
Massachusetts General Hospital
Boston 4930956, Massachusetts 6254926, 02114
Status
Address
Dana-Farber Cancer Institute
Boston 4930956, Massachusetts 6254926, 02215
Status
Address
Karmanos Cancer Institute
Detroit 4990729, Michigan 5001836, 48201
Status
Address
Rutgers Cancer Institute of New Jersey
New Brunswick 5101717, New Jersey 5101760, 08901
Status
Address
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York 5128581, New York 5128638, 10016
Status
Address
Columbia University
New York 5128581, New York 5128638, 10032
Status
Address
University of Rochester
Rochester 5134086, New York 5128638, 14642
Status
Address
Lineberger Comprehensive Cancer Center
Chapel Hill 4460162, North Carolina 4482348, 27599
Status
Address
Duke Cancer Institute, University Hospital
Durham 4464368, North Carolina 4482348, 27710
Status
Address
University Hospitals Cleveland Medical Center
Cleveland 5150529, Ohio 5165418, 44106
Status
Address
Cleveland Clinic Foundation
Cleveland 5150529, Ohio 5165418, 44195
Status
Address
The Ohio State University James Comprehensive Cancer Center
Columbus 4509177, Ohio 5165418, 43210
Status
Address
St Lukes University Health Network
Easton 5188140, Pennsylvania 6254927, 18045
Status
Address
University Of Pittsburgh
Pittsburgh 5206379, Pennsylvania 6254927, 15213
Status
Address
University of Tennessee Medical Center
Knoxville 4634946, Tennessee 4662168, 37920
Status
Address
Tennessee Oncology - Centennial Clinic Location
Nashville 4644585, Tennessee 4662168, 37203-1625
Status
Address
Verdi Oncology
Nashville 4644585, Tennessee 4662168, 37203
Status
Address
UT Southwestern Medical Center
Dallas 4684888, Texas 4736286, 75390
Status
Address
Intermountain Medical Center
Murray 5778755, Utah 5549030, 84107
Status
Address
University of Virginia Medical Center
Charlottesville 4752031, Virginia 6254928, 22903
International Sites
Status
Address
Fundacion Centro de Investigaciones para la Transformacion (CENIT)
Caba, Buenos Aires 3435907, 1125
Status
Address
Centro de Investigacion Pergamino
Pergamino 3841490, Buenos Aires 3435907, B2700CPM
Status
Address
Clinica Viedma S.A.
Viedma 3832899, Río Negro Province 3838830, 8500
Status
Address
Instituto de Oncologia de Rosario
Rosario 3838583, Santa Fe Province 3836276, S2000KZE
Status
Address
Centro Medico San Roque
San Miguel de Tucumán 3836873, Tucumán Province 3833578, 4000
Status
Address
DIABAID - Instituto de Asistencia Integral en Diabetes
Caba, , 1061
Status
Address
Blacktown Cancer and Haematology Centre - Blacktown Hospital
Blacktown 2175411, New South Wales 2155400, 2148
Status
Address
Lismore Base Hospital
Lismore 2160063, New South Wales 2155400, 2480
Status
Address
Liverpool Hospital - Cancer Therapy Centre
Liverpool 2159851, New South Wales 2155400, 2170
Status
Address
Melanoma Institute of Australia
Wollstonecraft 9972972, New South Wales 2155400, 2065
Status
Address
Flinders Medical Centre
Bedford Park 2076918, South Australia 2061327, 5042
Status
Address
Calvary North Adelaide Hospital
North Adelaide 8469169, South Australia 2061327, 5006
Status
Address
Eastern Health
Box Hill 2174360, Victoria 2145234, 3128
Status
Address
Andrew Love Cancer Centre
Geelong 2165798, Victoria 2145234, 3220
Status
Address
Alfred Hospital
Melbourne 2158177, Victoria 2145234, 3004
Status
Address
One Clinical Research at Hollywood Private Hospital
Nedlands 2064874, Western Australia 2058645, 6009
Status
Address
Vitaz campus Sint-Niklaas Moerland
Sint-Niklaas 2786578, Oost-Vlaanderen, 9100
Status
Address
AZ Groeninge
Kortrijk 2794055, West-Vlaanderen, 8500
Status
Address
Cliniques Universitaires Saint-Luc
Brussels 2800866, , 1200
Status
Address
Hospital das Clinicas da Universidade Federal de Minas Gerais
Belo Horizonte 3470127, Minas Gerais 3457153, 30130-090
Status
Address
Liga Paranaense de Combate ao Cancer - Hospital Erasto Gaertner
Curitiba 3464975, Paraná 3455077, 81520-060
Status
Address
INCA Instituto Nacional de Cancer
Santo Cristo 7538667, Rio de Janeiro 3451189, 20220-410
Status
Address
Oncosite Centro De Pesquisa Em Oncologia
Ijuí 3461444, Rio Grande do Sul 3451133, 98700-000
Status
Address
Instituto do Cancer em Hospital Sao Vicente de Paulo
Passo Fundo 3454857, Rio Grande do Sul 3451133, 99010-090
Status
Address
Hospital de Clinicas de Porto Alegre
Porto Alegre 3452925, Rio Grande do Sul 3451133, 90035007
Status
Address
Hospital Moinhos de vento
Porto Alegre 3452925, Rio Grande do Sul 3451133, 90440140
Status
Address
Centro de Pesquisa em Oncologia PUCRS
Porto Alegre 3452925, Rio Grande do Sul 3451133, 90619900
Status
Address
Catarina Pesquisa Clinica
Itajaí 3460845, Santa Catarina 3450387, 88301-220
Status
Address
Instituto Joinvilense de Hematologia e Oncologia
Joinville 3459712, Santa Catarina 3450387, 89201260
Status
Address
Animi Unidade de Tratamento Oncologico
Lages 3458930, Santa Catarina 3450387, 88501-001
Status
Address
Fundacao Pio XII - Hospital de Amor
Barretos 3470451, São Paulo 3448433, 14784400
Status
Address
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto - Hospital de Base
São José do Rio Preto 3448639, São Paulo 3448433, 15090-000
Status
Address
Unimed Sorocaba
Sorocaba 3447399, São Paulo 3448433, 18052-210
Status
Address
Instituto COI
Rio de Janeiro 3451190, , 23793-080
Status
Address
Hemomed
São Paulo 3448439, , 01236030
Status
Address
Hospital Sirio Libanes
São Paulo 3448439, , 01308-050
Status
Address
Sao Camilo Oncologia
São Paulo 3448439, , 04014-002
Status
Address
Dr. Everett Chalmers Hospital
Fredericton 5957776, New Brunswick 6087430, E3B 5N5
Status
Address
Royal Victoria Regional Health Centre
Barrie 5894171, Ontario 6093943, L4M 6M2
Status
Address
Sunnybrook Health Sciences Centre
Toronto 6167865, Ontario 6093943, M4N 3M5
Status
Address
Princess Margaret Cancer Centre
Toronto 6167865, Ontario 6093943, M5G 2M9
Status
Address
Oncocentro APYS
Viña del Mar 3868121, Región de Valparaíso 3868621, 2520598
Status
Address
Clinica UC San Carlos de Apoquindo
Santiago 3871336, Santiago Metropolitan 3873544, 7550000
Status
Address
Centro Oncologia de Precision Universidad Mayor
Santiago 3871336, Santiago Metropolitan 3873544, 7560907
Status
Address
Masaryk Memorial Cancer Institute
Brno 3078610, Brno Mesto, 65653
Status
Address
University Hospital Hradec Kralove
Hradec Králové 3074967, North Central Czech Republic, 50005
Status
Address
University Hospital Ostrava
Ostrava 3068799, , 70852
Status
Address
Centre Georges Francois Leclerc
Dijon 3021372, Bourgogne, 21000
Status
Address
CHU-Dijon
Dijon 3021372, Burgundy, 21000
Status
Address
Besancon Regional University Hospital Center
Besançon 3033123, Doubs, 25000
Status
Address
Chu De Bordeaux
Bordeaux 3031582, Gironde, 33075
Status
Address
Institut Claudius Regaud, IUCT-Oncopole
Toulouse 2972315, Haute-Garonne, 31059
Status
Address
CHU de Lille
Lille 2998324, Hauts-de-France 11071624, 59000
Status
Address
Service de Dermatologie CHU Saint Eloi
Montpellier 2992166, Herault, 34295
Status
Address
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche 3006131, Isere, 38700
Status
Address
Centre Francois Baclesse (CFB)
Caen 3029241, Normandy 11071621, 14076
Status
Address
Centre Hospitalier Le Mans
Le Mans 3003603, Pays de la Loire Region 2988289, 72037
Status
Address
Nantes University Hospital
Nantes 2990969, Pays de la Loire Region 2988289, 44093
Status
Address
CHU Amiens-Picardie
Amiens 3037854, Picardie, 80000
Status
Address
Sainte Catherine Institut du Cancer Avignon Provence
Avignon 3035681, , 84918
Status
Address
N_Hôpital Ambroise-Paré
Boulogne-Billancourt 3031137, , 92100
Status
Address
CHU Estaing
Clermont-Ferrand 3024635, , 63003
Status
Address
Centre Hospitalier Universitaire De Nice Hopital De L Archet
Nice 2990440, , 06202
Status
Address
Centre Hospitalier de Valence
Valence 2971053, , 26000
Status
Address
Institut Gustave Roussy
Villejuif 2968705, , 94805
Status
Address
Hopital Avicenne
Bobigny 3032179, Île-de-France Region 3012874, 93000
Status
Address
Hospital Henri Mondor
Créteil 3022530, Île-de-France Region 3012874, 94000
Status
Address
Saint Louis Hospital
Paris 2988507, Île-de-France Region 3012874, 75010
Status
Address
Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
Tbilisi 611717, Caucasus, 0144
Status
Address
Cancer Center of Adjara
Batumi 615532, , 6000
Status
Address
Acad.Fridon Todua Medical Center- Research Institute of Clinical Medicine
Tbilisi 611717, , 0112
Status
Address
Israeli Georgian Medical Research Clinic Helsicore
Tbilisi 611717, , 0112
Status
Address
LTD New Hospitals
Tbilisi 611717, , 0114
Status
Address
JSC K. Eristavi National Center of Experimental and Clinical Surgery
Tbilisi 611717, , 0159
Status
Address
TIM - Tbilisi Institute of Medicine
Tbilisi 611717, , 0160
Status
Address
University Medical Center Mannheim
Mannheim 2873891, Baden-Wurttemberg 2953481, 68167
Status
Address
University of Tuebingen
Tübingen 2820860, Baden-Wurttemberg 2953481, 72076
Status
Address
University Hospital Augsburg
Augsburg 2954172, Bavaria 2951839, 86179
Status
Address
Dermatology Erlangen
Erlangen 2929567, Bavaria 2951839, 91054
Status
Address
LMU Klinikum
Munich 2867714, Bavaria 2951839, 80337
Status
Address
University Hospital of Regensburg
Regensburg 2849483, Bavaria 2951839, 93053
Status
Address
Klinikum Darmstadt GmbH
Darmstadt 2938913, Hesse 2905330, 64283
Status
Address
University Clinic Frankfurt
Frankfurt am Main 2925533, Hesse 2905330, 60590
Status
Address
University Medical Center Goettingen
Göttingen 2918632, Lower Saxony 2862926, 37075
Status
Address
Helios Kliniken Schwerin
Schwerin 2834282, Mecklenburg-Vorpommern 2872567, 19055
Status
Address
Ruhr University Bochum
Bochum 2947416, North Rhine-Westphalia 2861876, 44791
Status
Address
Universitatsklinikum Essen
Essen 2928810, North Rhine-Westphalia 2861876, 45147
Status
Address
University Hospital Muenster
Münster 2867543, North Rhine-Westphalia 2861876, 48149
Status
Address
Fachklinik Hornheide
Münster 2867543, North Rhine-Westphalia 2861876, 48157
Status
Address
Hautklinik
Ludwigshafen am Rhein 2875376, Rhineland-Palatinate 2847618, D-67063
Status
Address
University Hospital Dresden
Dresden 2935022, Saxony 2842566, 01307
Status
Address
Skin Cancer Center Harz
Quedlinburg 2851465, Saxony-Anhalt 2842565, 06484
Status
Address
University Hospital of Universitatsklinikum Schleswig Holstein (UKSH) Campus Kiel
Kiel 2891122, Schleswig-Holstein 2838632, 24105
Status
Address
Universitatsklinikum Schleswig Holstein Campus Luebeck
Lübeck 2875601, Schleswig-Holstein 2838632, 23538
Status
Address
Helios Klinikum Erfurt
Erfurt 2929670, Thuringia 2822542, D-99089
Status
Address
Charite Universitaetsmedizin Berlin
Berlin 2950159, , 10117
Status
Address
Klinikum Bremen Ost
Bremen 2944388, , 28325
Status
Address
National and Kapodistrian University of Athens
Athens 264371, Attica 6692632, 11527
Status
Address
Metropolitan Hospital
Neo Faliro 256495, Attica 6692632, 18547
Status
Address
Ongology Theageneio Thessaloniki
Thessaloniki 734077, , 54007
Status
Address
BioClinic Thessaloniki
Thessaloniki 734077, , 54622
Status
Address
Interbalkan Medical Center
Thessaloniki 734077, , 57001
Status
Address
Galway University Hospital
Galway 2964180, Connacht 7521313, H91 YR71
Status
Address
Cork University Hospital
Cork 2965140, , T12 EC8P
Status
Address
Beaumont Hospital
Dublin 2964574, , D09 V2N0
Status
Address
St Vincents University Hospital
Dublin 2964574, , DO4YN63
Status
Address
Haemek Medical Center
Afula 295740, Northern District 294824, 18340000
Status
Address
Hadassah Medical Organization
Jerusalem 281184, , 91120
Status
Address
Sheba Medical Center
Tel Litwinsky 293361, , 5265601
Status
Address
Clinica Oncologica, AOU Riuniti Ancona
Ancona 3183089, An, 60020
Status
Address
U.O.C. Oncologia Medica ed Ematologia (U.O.C Medical Oncology and Hematology)
Naples 3172394, Campania 3181042, 80121
Status
Address
Istituto Romagnolo per lo Studio dei Tumori (IRST)
Meldola 3173635, Forli Cesena, 47014
Status
Address
Istituto Clinico Humanitas
Milan 3173435, Lombardy 3174618, 20089
Status
Address
Istituto dei Tumori
Bari 3182351, , 70124
Status
Address
Azienda Ospedaliera Santa Croce i Carle
Cuneo 3177700, , 12100
Status
Address
Istituto Europeo di Oncologia
Milan 6951411, , 20141
Status
Address
Instituto Nazionale Tumori Fondazione Giovanni Pascale
Naples 3172394, , 80131
Status
Address
University of Perugia
Perugia 3171180, , 06132
Status
Address
Fondazione Policlinico Universitrio a. Gemelli - IRCCS
Rome 3169070, , 000168
Status
Address
Campus Bio-Medico di Roma
Rome 3169070, , 00128
Status
Address
Istituto Dermopatico dell'Immacolata
Rome 3169070, , 00167
Status
Address
Santa Chiara Hospital
Trento 3165243, , 38122
Status
Address
Azienda Sanitaria Universitaria del Friuli Centrale
Udine 3165072, , 33100
Status
Address
Preparaciones Oncologica SC
León 3998655, Guanajuato 4005267, 37178
Status
Address
Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde
Guadalajara 4005539, Jalisco 4004156, 44280
Status
Address
Pan American Clinical Research
Guadalajara 4005539, Jalisco 4004156, 44670
Status
Address
iCan Oncology
Monterrey 3995465, Nuevo León 3522542, 64710
Status
Address
Neurociencias Estudios Clinicos SC
Culiacán 4012176, Sinaloa 3983035, 80020
Status
Address
Centro De Atencion E Investigacion Clinica En Oncologia SCP
Mérida 3523349, Yucatán 3514211, 97134
Status
Address
Faicic Centro de Investigacion Clinica de Veracruz
Veracruz 3514783, , 91910
Status
Address
Mazowiecki Szpital Wojewodzki, Siedleckie Centrum Onkologii
Siedlce 759412, Mazxowieckie, 08-110
Status
Address
UCK
Gdansk 3099434, Pomeranian Voivodeship 3337496, 80-214
Status
Address
Copernicus Podmiot Leczniczy Sp. z o.o.Wojewodzie Centrum Onkologii
Gdansk 3099434, Pomeranian Voivodeship 3337496, 80-219
Status
Address
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Słupsku Sp. z o.o.
Słupsk 3085450, Pomeranian Voivodeship 3337496, 76-200
Status
Address
Poznan University of Meidcla Science
Poznan 3088171, Wielkopolska, 60-788
Status
Address
Institute of Oncology Bucharest
Bucharest 683506, București 683504, 022328
Status
Address
Cardiomed
Cluj-Napoca 681290, Cluj 681291, 400015
Status
Address
Institute of Oncology Prof. Dr Ion Chirircuta
Cluj-Napoca 681290, Cluj 681291, 400015
Status
Address
Radiotherapy Center Cluj
Floreşti 678050, Cluj 681291, 407280
Status
Address
Sfantul Nectarie Oncology Center
Craiova 680332, Dolj 679134, 200347
Status
Address
Oncocenter Oncologie Clinica S.R.L
Timișoara 665087, Timiș County 665091, 300166
Status
Address
Oncomed
Timișoara 665087, Timiș County 665091, 300239
Status
Address
Centrul De Oncologie Euroclinic
Iași 675810, , 700106
Status
Address
The Medical Oncology Centre of Rosebank
Johannesburg 993800, Gauteng 1085594, 2196
Status
Address
Wilgers Oncology Centre
Pretoria 964137, Gauteng 1085594, 0081
Status
Address
Groote Schuur Hospital
Cape Town 3369157, Western Cape 1085599, 7925
Status
Address
Cape Town Oncology Trials
Kraaifontein 3365083, Western Cape 1085599, 7570
Status
Address
H. Germans Trias i Pujol, ICO-Badalona
Badalona 3129028, Barcelona, 08916
Status
Address
Hospital Universitario Marques de Valdecilla
Santander 3109718, Cantabria 3336898, 39008
Status
Address
Instituto Oncologico Dr Rosell Hospital Universitari Quiron Dexeus Location
Barcelona 3128760, Catalonia 3336901, 08028
Status
Address
Hospital Universitario Central De Asturias
Oviedo 3114711, Principality of Asturias 3114710, 33011
Status
Address
Hospital Vall d'Hebron
Barcelona 3128760, , 08035
Status
Address
Hospital Clinic de Barcelona
Barcelona 3128760, , 08036
Status
Address
Catalan Institute of Oncology (ICO) Hospitalet
Barcelona 3128760, , 08908
Status
Address
Hospital Universitario Virgen de las Nieves
Granada 2517117, , 18014
Status
Address
Hospital Universitario Lucus Augusti
Lugo 3117814, , 27003
Status
Address
Hospital General Universitario Gregorio Maranon
Madrid 3117735, , 28007
Status
Address
Hospital Universitario 12 de Octubre Universidad Complutense de Madrid UCM
Madrid 3117735, , 28041
Status
Address
Hospital Universitario La Pa<
Madrid 3117735, , 28046
Status
Address
Centro Integral Oncologico HM Clara Campal
Madrid 3117735, , 28050
Status
Address
Hospital Universitario Virgen Macarena
Seville 2510911, , 41009
Status
Address
Instituto Valenciano de Oncologia
Valencia 2509954, , 46009
Status
Address
Incliva - Instituto de Investigacion Sanitaria
Valencia 2509954, , 46010
Status
Address
Baskent University
Yüreğir 323716, Adana 325361, 01230
Status
Address
Dicle University - Medical Faculty Campus
Sur 10048774, Diyarbakır 316540, 21200
Status
Address
Kocaeli University
İzmit 745028, Kocaeli 742865, 41380
Status
Address
Gaziantep Medicalpoint Hospital
Gaziantep 314830, Sehitkamil, 27584
Status
Address
Gulhane Research And Training Hospital
Ankara 323786, , 06010
Status
Address
Ozel Liv Hospital
Ankara 323786, , 06100
Status
Address
Sbu Doctor Abdurrahman Yurtaslan Ankara Onkoloji Suam
Ankara 323786, , 06100
Status
Address
Memorial Ankara Hospital
Ankara 323786, , 0906520
Status
Address
Trakya University
Edirne 747712, , 22030
Status
Address
Istanbul University Cerrahpasa at Cerrahpasa Medical Faculty
Istanbul 745044, , 34450
Status
Address
Istanbul Medeniyet University - Prof Dr Suleyman Yalcin Sehir Hospital
Istanbul 745044, , 81450
Status
Address
Royal Devon and Exeter Hospital NHS Trust
Exeter 2649808, Devon, EX2 5DW
Status
Address
Edinburgh Cancer Centre
Edinburgh 2650225, Lothian, EH4 2XU
Status
Address
Bristol Haematology And Oncology Centre (BHOC) - Bristol Cancer Institute
Bristol 2654675, Somerset, BS2 8ED
Status
Address
The Royal Marsden NHS Foundation Trust
Sutton 2636503, Surrey, SM2 5PT
Status
Address
University Hospital Coventry and Warwickshire Nhs Trust
Coventry 2652221, West Midlands, CV2 2DX
Status
Address
Saint Bartholomew's Hospital
London 2643743, , EC1A 7BE
Status
Address
University College London Hospitals
London 2643743, , NW1 2PG
Status
Address
The Christie
Manchester 2643123, , M20 4BX
Status
Address
Taunton and Somerset NHS Foundation Trust
Taunton 2636177, , TA1 5DA
